mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-07 |
mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
3e-07 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-07 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-07 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
5e-07 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
6e-07 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
6e-07 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
6e-07 |
mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
8e-07 |
mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-06 |